Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-19
2011-04-19
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S578000
Reexamination Certificate
active
07928099
ABSTRACT:
The present invention provides a compound of formula (I):or a pharmaceutically acceptable salt thereof wherein the variables R1, R2, R3a, R3b, R3b, R3d, and R100are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a 5-HT2creceptor-mediated disorders with a compound of formula (I) or a pharmaceutical composition comprising a compound of formula (I).
REFERENCES:
patent: 2007/0032481 (2007-02-01), Dvorak et al.
patent: 2007/0225275 (2007-09-01), Allison et al.
patent: 1552842 (2005-07-01), None
patent: WO 2006044762 (2006-04-01), None
patent: WO 2007019083 (2007-02-01), None
patent: WO 2007109355 (2007-09-01), None
patent: WO 2007146122 (2007-12-01), None
Andrews Mark
Blagg Julian
Brennan Paul
Fish Paul
Storer R. Ian
Coleman Brenda L
Kispert Jennifer A.
Pfizer Inc
Wichtowski John A.
LandOfFree
Pyrimido [4,5-D] azepine derivatives as 5-HT 2c agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimido [4,5-D] azepine derivatives as 5-HT 2c agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimido [4,5-D] azepine derivatives as 5-HT 2c agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2683402